Doctor Kei Yoshioka
Kansai Medical University Medical Center, Osaka (Japan)
Impact of early tolvaptan treatment for very elderly patients with heart failure and chronic kidney disease
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Diuretics
Session: Chronic heart failure
Tolvaptan is useful and safe for the treatment of very elderly patients with heart failure and chronic kidney disease
Event: HEART FAILURE 2016
Topic: Chronic nursing care
Session: Chronic heart failure
